Evidence map›Paper›PMID 23628287›Full record

ReviewCurrent opinion in structural biology2013

Baculovirus expression: tackling the complexity challenge.

David Barford, Yuichiro Takagi, Patrick Schultz, Imre Berger

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in structural biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Towards routine accurate electron-density studies of biological macromolecules.Acta crystallographica. Section D, Structural biology · 2026
    Article
  2. Article
  3. VLP-factory™ and ADDomerCurrent protocols · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Development of a full-length human protein production pipeline.Protein science : a publication of the Protein Society · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 3 countries.

David BarfordDivision of Structural Biology, Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London SW3 6JB, UK.
Yuichiro Takagi
Patrick Schultz
Imre Berger
Indiana University School of MedicineInserm · FRInstitute of Cancer Research · GBUnit of Virus Host Cell Interactions · FR

Funding

Cancer Research UK 14109Medical Research Council MC_UP_1201/6
6 · The paper itself

Abstract

Most essential functions in eukaryotic cells are catalyzed by complex molecular machines built of many subunits. To fully understand their biological function in health and disease, it is imperative to study these machines in their entirety. The provision of many essential multiprotein complexes of higher eukaryotes including humans, can be a considerable challenge, as low abundance and heterogeneity often rule out their extraction from native source material. The baculovirus expression vector system (BEVS), specifically tailored for multiprotein complex production, has proven itself to be uniquely suited for overcoming this impeding bottleneck. Here we highlight recent major achievements in multiprotein complex structure research that were catalyzed by this versatile recombinant complex expression tool.

Indexed as

BaculoviridaeAnaphase-Promoting Complex-CyclosomeAnimalsCloning, MolecularGenetic VectorsHumansInsectaMediator ComplexMultiprotein ComplexesRecombinant ProteinsSaccharomyces cerevisiae ProteinsAnaphase-Promoting Complex-CyclosomeMediator ComplexMultiprotein ComplexesRecombinant ProteinsSaccharomyces cerevisiae Proteins

Identifiers

PMID23628287
PMCPMC7125881
OpenAlexW2084259842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.